<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.65.e95802</article-id>
      <article-id pub-id-type="publisher-id">95802</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Socket preservation using a combination of propolis extract and bovine bone graft towards the expression of receptor activator of nuclear κB ligand and osteoprogerin</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Kresnoadi</surname>
            <given-names>Utari</given-names>
          </name>
          <email xlink:type="simple">utari-k@fkg.unair.ac.id</email>
          <uri content-type="orcid">https://orcid.org/0000-0002-5076-4629</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Sari</surname>
            <given-names>Nila</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-6397-4107</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Laksono</surname>
            <given-names>Harry</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-8708-4731</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Prosthodontics, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia</addr-line>
        <institution>Universitas Airlangga</institution>
        <addr-line content-type="city">Surabaya</addr-line>
        <country>Indonesia</country>
      </aff>
      <author-notes>
        <fn>
          <p>Utari Kresnoadi, Department of Prosthodontics, Faculty of Dental Medicine, Universitas Airlangga, Jl. ﻿Mayjend Prof. Dr. Moestopo 47, Surabaya 60132, Indonesia; Email: <email xlink:type="simple">utari-k@fkg.unair.ac.id</email>; Tel.: +62315030255</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2023</year>
      </pub-date>
      <volume>65</volume>
      <issue>5</issue>
      <fpage>737</fpage>
      <lpage>743</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/95D2C089-D303-5B34-8B1F-88830D5076DF">95D2C089-D303-5B34-8B1F-88830D5076DF</uri>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>03</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Utari Kresnoadi, Nila Sari, Harry Laksono</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p><bold>Aim</bold>: This study was undertaken to comprehend the effect of a combination of bovine bone graft (<abbrev xlink:title="bovine bone graft" id="ABBRID0EQD">BBG</abbrev>) and propolis extract on the receptor activator of nuclear κB ligand (<abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EUD">RANKL</abbrev>) and osteoprotegerin (<abbrev xlink:title="osteoprotegerin" id="ABBRID0EYD">OPG</abbrev>) expressions in post-extraction tooth sockets.</p>
        <p><bold>Materials and methods</bold>: Fifty-six male Cavia Cobayas were divided into eight groups each containing seven subjects. The lower left incisor of each subject was removed prior to four different materials - polyethylene glycol (<abbrev xlink:title="polyethylene glycol" id="ABBRID0EAE">PEG</abbrev>), propolis extract+<abbrev xlink:title="polyethylene glycol" id="ABBRID0EEE">PEG</abbrev>, <abbrev xlink:title="bovine bone graft" id="ABBRID0EIE">BBG</abbrev>+<abbrev xlink:title="polyethylene glycol" id="ABBRID0EME">PEG</abbrev>, and propolis extract+<abbrev xlink:title="bovine bone graft" id="ABBRID0EQE">BBG</abbrev>+<abbrev xlink:title="polyethylene glycol" id="ABBRID0EUE">PEG</abbrev> (combination) being applied to the post-extraction sockets. The laboratory animals were sacrificed at three and seven days. An immunohistochemical examination was subsequently performed to observe the expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EYE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0E3E">OPG</abbrev> using a light microscope at 1000× magnification.</p>
        <p><bold>Results</bold>: The mean expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EEF">RANKL</abbrev> on the third and seventh days was the lowest in the combination group, while the mean <abbrev xlink:title="osteoprotegerin" id="ABBRID0EIF">OPG</abbrev> expression on those days was the highest in the combination group. The one-way ANOVA tests conducted on each group produced a <italic>p</italic> value &lt;0.05 indicating that significant differences existed between certain groups. A Pearson’s correlation test conducted on both observation day groups highlighted the opposite correlation of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EOF">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0ESF">OPG</abbrev>.</p>
        <p><bold>Conclusions</bold>: A combination of propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0E1F">BBG</abbrev> effectively upregulates <abbrev xlink:title="osteoprotegerin" id="ABBRID0E5F">OPG</abbrev> expression and downregulates <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ECG">RANKL</abbrev> expression in the preserved post-extraction socket.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>bone graft</kwd>
        <kwd>medicine</kwd>
        <kwd>OPG</kwd>
        <kwd>propolis</kwd>
        <kwd>RANKL</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0EOG">
        <title>Citation</title>
        <p>Kresnoadi U, Sari N, Laksono H. Socket preservation using a combination of propolis extract and bovine bone graft towards the expression of receptor activator of nuclear κB ligand and osteoprogerin. Folia Med (Plovdiv) 2023;65(5):737-743. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3897/folmed.65.e95802">10.3897/folmed.65.e95802</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="Introduction" id="SECID0E1G">
      <title>Introduction</title>
      <p>According to Indonesia’s Basic Health Research (Riset Kesehatan Dasar/RISKESDAS), oral health problems in 2018 affected 57.6% of Indonesia’s population.<sup>[<xref ref-type="bibr" rid="B1">1</xref>]</sup> Such problems often culminate in tooth extraction, while the healing process in the resulting socket induces resorption of the alveolar process, both vertically and horizontally.<sup>[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]</sup></p>
      <p>The initial phase of the healing process is characterized by blood clotting and the migration of inflamed cells which releases cytokines such as the insulin growth factor-I (<abbrev xlink:title="insulin growth factor-I" id="ABBRID0ETH">IGF-I</abbrev>), parathyroid hormone (<abbrev xlink:title="parathyroid hormone" id="ABBRID0EXH">PTH</abbrev>), tumor necrosis factor-α (<abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0E2H">TNF-α</abbrev>), and interleukin-6 (<abbrev xlink:title="interleukin-6 " id="ABBRID0EAAAC">IL-6</abbrev>). These cytokines activate osteoblasts culminating in the expressing of the receptor activator of the nuclear κB ligand (<abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EEAAC">RANKL</abbrev>). <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EIAAC">RANKL</abbrev> binds to this receptor activator of nuclear <italic>κ</italic>B (RANK) and initiates osteoclast differentiation, which subsequently resorbs the bone and, on completion of this function, undergoes an apoptotic process. In addition to <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EOAAC">RANKL</abbrev>, osteoblasts will express osteoprotegerin (<abbrev xlink:title="osteoprotegerin" id="ABBRID0ESAAC">OPG</abbrev>), the decoy receptor of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EWAAC">RANKL</abbrev> that can inhibit the <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E1AAC">RANKL</abbrev>-RANK bond in osteoclastogenesis.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup></p>
      <p>The inflammation phase will be followed by a proliferation phase characterized by the rapid formation of new tissue. From the second week after extraction, provisional matrix deposition will be followed by the penetration of the blood vessels, bone forming cells, and projections of the woven bone over a period of several weeks. The final phases consist of bone modeling and bone remodeling. The former is characterized by changes in bone shape due to bone resorption that will affect the alveolar ridge dimension, while the latter constitutes a change, such as the remodeling of woven bone into lamellar bone that leaves the shape of the bone unaltered. Resorption of osteoclasts activities occurs in the socket.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup></p>
      <p>Post-extraction alveolar bone resorption occurs rapidly in the first year but at a slower rate in subsequent years. The first year sees the loss of 25% of bone width, a figure that increases to up to 40% in the third year.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup></p>
      <p>Alveolar bone resorption is unsuitable for prosthodontic treatments. The treatment success rate will be higher if the bone volume is adequate. Prosthodontic treatments require an adequate bone height in order for them to prove effective and have a positive aesthetic outcome. Alveolar bone loss greater than 7 mm potentially complicates prosthodontic treatment<sup>[<xref ref-type="bibr" rid="B6">6</xref>]</sup>, which is the reason for clinicians ideally maintaining as much bone height as possible. One treatment is intended to preserve the post-extraction socket to avoid the need for clinicians to undertake more invasive bone augmentation procedures in the future.<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup></p>
      <p>Maintaining post-extraction bone dimensions can be achieved through the application of a bone graft, with the xenograft being one of the most frequently used varieties in dentistry. This variety of graft is biocompatible with, and structurally similar to, human bone. Xenograft, the variety most frequently used being bovine xenograft<sup>[<xref ref-type="bibr" rid="B8">8</xref>]</sup>, possesses osteoconductive properties with the result that interposition with connective tissue is rare.</p>
      <p>Another material used in this study was propolis extract. Propolis is a natural product in the form of a resin collected by honeybees from various plants. Bees use propolis as the material from which to build their nests and render it resistant to bacterial and fungal infection. Propolis not only acts as an anti-microorganism agent, but also as an antioxidant and anti-inflammatory agent. The antioxidant property of propolis is derived from flavonoid and polyphenol, substances that can remove free radicals from tissue, thereby supporting the regulation of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EOCAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0ESCAC">OPG</abbrev>. The expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EWCAC">RANKL</abbrev> can be increased, while that of <abbrev xlink:title="osteoprotegerin" id="ABBRID0E1CAC">OPG</abbrev> can be decreased due to their sensitivity to the level of oxidative.‌<sup>[<xref ref-type="bibr" rid="B9">9</xref>]</sup> The chrysin content of propolis can reduce the expression of <abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0EFDAC">TNF-α</abbrev>, interleukin-1β (IL-1β), and <abbrev xlink:title="interleukin-6" id="ABBRID0EJDAC">IL-6</abbrev>. Cytokines perform specific roles in regulating <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ENDAC">RANKL</abbrev> expression by osteoblasts.<sup>[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]</sup></p>
      <p>Bone remodeling is highly dependent on osteoclast and osteoblast activity. These cells have numerous cell markers that can be studied. <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E4DAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EBEAC">OPG</abbrev> are important markers in osteoclastogenesis. A study by Arnez et al. describes how <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFEAC">RANKL</abbrev> expression increases at 7 and 10 days, while that of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EJEAC">OPG</abbrev> increases at 3 and 7 days. In this study, the expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ENEAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EREAC">OPG</abbrev> during socket preservation, using propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0EVEAC">BBG</abbrev> combination, was observed on the third and seventh days.<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup></p>
    </sec>
    <sec sec-type="Aim" id="SECID0E6EAC">
      <title>Aim</title>
      <p>The present study aimed to comprehend the effect of a combination of <abbrev xlink:title="bovine bone graft" id="ABBRID0EFFAC">BBG</abbrev> and propolis extract on the <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJFAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0ENFAC">OPG</abbrev> expressions in post-extraction tooth sockets.</p>
    </sec>
    <sec sec-type="materials|methods" id="SECID0ERFAC">
      <title>Materials and methods</title>
      <p>This study has been reviewed and approved by the Ethical Clearance Committee, Faculty of Dental Medicine and issued with approval number 556/HRECC.FODM/VIII/2019.</p>
      <sec sec-type="Animal characteristics" id="SECID0EWFAC">
        <title>Animal characteristics</title>
        <p>This study involved 56 male Cavia Cobayas, 300–350 grams in weight and 3–3.5 months old, which were divided into eight groups of seven subjects each.</p>
      </sec>
      <sec sec-type="Procedures" id="SECID0E2FAC">
        <title>Procedures</title>
        <p>Before extraction of their lower left incisors, the animals were anesthetized by means of a 0.2-cc/300-g dose of ketamine. Following extraction, the sockets were filled with different materials according to the group. Suturing was performed using polyamide monofilament. These laboratory subjects were observed on the third and seventh days after application of the materials to the interior of the post-extraction sockets.</p>
        <p>These subjects were divided as follows: groups 1 and 2 (controls), the post-extraction socket received 25 g of polyethylene glycol (<abbrev xlink:title="polyethylene glycol" id="ABBRID0ECGAC">PEG</abbrev>); groups 3 and 4, the post-extraction socket was administered with 0.5 g of propolis extract and 24.5 g of <abbrev xlink:title="polyethylene glycol" id="ABBRID0EGGAC">PEG</abbrev>; groups 5 and 6, the post-extraction socket was given 0.5 g of <abbrev xlink:title="bovine bone graft" id="ABBRID0EKGAC">BBG</abbrev> and 24.5 gram of <abbrev xlink:title="polyethylene glycol" id="ABBRID0EOGAC">PEG</abbrev>; and groups 7 and 8, the post-extraction socket received 0.5 g of propolis extract, 0.5 g of <abbrev xlink:title="bovine bone graft" id="ABBRID0ESGAC">BBG</abbrev>, and 24 g of <abbrev xlink:title="polyethylene glycol" id="ABBRID0EWGAC">PEG</abbrev>. Groups 1, 3, 5, and 7 were observed on the third day, while groups 2, 4, 5, and 8 were monitored on the seventh day.</p>
      </sec>
      <sec sec-type="Immunostaining observation" id="SECID0E1GAC">
        <title>Immunostaining observation</title>
        <p>The research subjects were sacrificed, and their mandibles removed and decalcified using ethylene diamine tetra acetate (<abbrev xlink:title="ethylene diamine tetra acetate" id="ABBRID0EAHAC">EDTA</abbrev>) for a period of two months. The soft mandibles were made into paraffin blocks, which were subsequently cut using a microtome (4 µ) to make immunohistochemistry slides. After deparaffinization, the slides were stained using monoclonal <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EEHAC">RANKL</abbrev> antibodies (12A668, Novus Biologicals, dilution 1:200) and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EIHAC">OPG</abbrev> (98A1071, Novus Biologicals, dilution 1:200). The <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EMHAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EQHAC">OPG</abbrev> expression in the osteoblasts were observed under a light microscope at magnification 1000× and from 20 visual fields.</p>
      </sec>
      <sec sec-type="Statistical analysis" id="SECID0EUHAC">
        <title>Statistical analysis</title>
        <p>The data generated by this experiment were statistically analyzed using a Statistical Package for Social Science (SPSS) version 23.0 (IBM Corporation, Illinois, Chicago, United States). A One-way ANOVA and Tukey HSD were employed to analyze the <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E1HAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0E5HAC">OPG</abbrev> expression.</p>
      </sec>
    </sec>
    <sec sec-type="Results" id="SECID0ECIAC">
      <title>Results</title>
      <p>﻿The highest means of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EIIAC">RANKL</abbrev> expression in the third- and seventh-day observation groups occurred in the control groups followed by the propolis extract groups, the <abbrev xlink:title="bovine bone graft" id="ABBRID0EMIAC">BBG</abbrev>-groups and, finally, the propolis extract-<abbrev xlink:title="bovine bone graft" id="ABBRID0EQIAC">BBG</abbrev> combination groups. The highest means of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EUIAC">OPG</abbrev> expression in the third- and seventh-day observation groups were found in the propolis extract-<abbrev xlink:title="bovine bone graft" id="ABBRID0EYIAC">BBG</abbrev> combination groups, followed by the <abbrev xlink:title="bovine bone graft" id="ABBRID0E3IAC">BBG</abbrev> groups, the propolis extract groups, with the lowest means occurring in the control groups <bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>.</p>
      <fig id="F1" position="float" orientation="portrait">
        <object-id content-type="arpha">FBD109E7-34E0-5794-BF16-1E5C51CC2946</object-id>
        <label>Figure 1.</label>
        <caption>
          <p>Chart describing mean numbers and standard deviations of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EPJAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0ETJAC">OPG</abbrev> expressions on the third and seventh days of study.</p>
        </caption>
        <graphic xlink:href="foliamedica-65-5-e95802-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_929262.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/929262</uri>
        </graphic>
      </fig>
      <p>The statistical test conducted during this experiment was a Shapiro-Wilk normality test, the result of which confirmed that the data was distributed normally (<italic>p</italic>&gt;0.05). A subsequent one-way ANOVA test whose significant value was &lt;0.05 indicated significant differences between certain groups. Consequently, a Tukey HSD test was conducted to identify the significant differences between each group. The picture of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EAKAC">OPG</abbrev> and <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EEKAC">RANKL</abbrev> expressions in this experiment was obtained using a light microscope from 20 visual fields <bold>(Fig. <xref ref-type="fig" rid="F2">2</xref>)</bold>.</p>
      <fig id="F2" position="float" orientation="portrait">
        <object-id content-type="arpha">2BF12670-4657-5E38-94DB-75F4FEE86345</object-id>
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EZKAC">RANKL</abbrev> expression on the third day; (<bold>B</bold>) <abbrev xlink:title="osteoprotegerin" id="ABBRID0E6KAC">OPG</abbrev> expression on the third day; (<bold>C</bold>) <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFLAC">RANKL</abbrev> expression on the seventh day; (<bold>D</bold>) <abbrev xlink:title="osteoprotegerin" id="ABBRID0ELLAC">OPG</abbrev> expression on the seventh day. The black arrows indicate the expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EPLAC">RANKL</abbrev> in (<bold>A</bold>) and (<bold>C</bold>); expression of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EXLAC">OPG</abbrev> in (<bold>B</bold>) and (<bold>D</bold>).</p>
        </caption>
        <graphic xlink:href="foliamedica-65-5-e95802-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_929263.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/929263</uri>
        </graphic>
      </fig>
      <p>The statistical analysis of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EGMAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EKMAC">OPG</abbrev> correlation shows that there are significant correlations between these two markers in both the third and the seventh day observation groups (Sig. (2-tailed) &lt;0.05). The third day observation group sig. (2-tailed) value was 0.010, while the seventh day observation group sig. (2-tailed) value was 0.000. A negative Pearson’s correlation value means that the subjects have an inverse relation. On the third observation day, the Pearson’s correlation value (<italic>r</italic>) was −0.480, signifying a moderate significant inverse correlation between <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EQMAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EUMAC">OPG</abbrev>. On the seventh observation day, the Pearson’s correlation value (<italic>r</italic>) was −0.665, which means that there was a strong significant inverse correlation between <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E1MAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0E5MAC">OPG</abbrev>.</p>
    </sec>
    <sec sec-type="Discussion" id="SECID0ECNAC">
      <title>Discussion</title>
      <p>The majority of tooth extractions will lead to significant resorption of the alveolar bone, which occurs because of the post-trauma healing process. Fifty percent of ridge width will be loss.<sup>[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>]</sup> Excessive amounts of bone loss will complicate prosthodontic treatment with the result that clinicians must invest considerable effort in preserving the alveolar bone. Socket preservation can be undertaken using bone graft to maintain bone dimension and avoid future invasive bone augmentation.<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup></p>
      <p>In this study, bone graft was combined with propolis extract as the socket preservation material. <abbrev xlink:title="bovine bone graft" id="ABBRID0E2NAC">BBG</abbrev> is a type of xenograft often used in dentistry due to its relatively greater availability and promotes osteoconductive activities<sup>[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>]</sup>, while propolis extract has anti-inflammation, anti-microorganisms, antioxidant, and immunomodulator properties.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> This combination is expected to accelerate the bone healing process.</p>
      <p><abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ETOAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EXOAC">OPG</abbrev> are important factors in bone healing which play essential roles in osteoclastogenesis. <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E2OAC">RANKL</abbrev> will bind to RANK, thereby inducing the osteoclastogenic process. The RANK-<abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E6OAC">RANKL</abbrev> bond will initiate osteoclast precursor differentiation to become mature osteoclast, stimulate bone resorption capacity, and reduce osteoclast apoptosis. In this process, <abbrev xlink:title="osteoprotegerin" id="ABBRID0EDPAC">OPG</abbrev> acts as an inhibitor, preventing <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EHPAC">RANKL</abbrev> from binding to RANK by binding to <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ELPAC">RANKL</abbrev>.<sup>[<xref ref-type="bibr" rid="B16">16</xref>]</sup></p>
      <p>The mean values of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EXPAC">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0E2PAC">OPG</abbrev> were observed on the third and seventh days. On each occasion, the lowest mean of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EAAAE">RANKL</abbrev> occurred in the propolis extract-<abbrev xlink:title="bovine bone graft" id="ABBRID0EEAAE">BBG</abbrev> combination groups, followed by the <abbrev xlink:title="bovine bone graft" id="ABBRID0EIAAE">BBG</abbrev> groups, then the propolis extract groups, while the highest mean was in the control group. The mean values of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EMAAE">OPG</abbrev> were the opposite of those of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EQAAE">RANKL</abbrev>. The lowest number occurred in the control groups, followed by the propolis extract group, while the highest number was in the group where a combination of propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0EUAAE">BBG</abbrev> was applied to the post-extraction socket.</p>
      <p>Bone graft is a material often employed to substitute for lost bone mass. Bone tissue demonstrates regenerative capability and can grow into the site provided by the graft. There are various types of bone graft such as autograft, allograft, xenograft and alloplast, although autograft is the gold standard in the field of dentistry. However, autograft requires an additional surgical site in order for the graft material to be obtained. Consequently, xenograft is used in this study due to its greater accessibility, osteoconductive properties, and structural similarity to human bone. Osteoconductivity in xenograft can support new bone growth inside the graft, with the result that interposition of connective tissue rarely occurs. Bovine bone graft is the most widely employed type of xenograft in dentistry.<sup>[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>]</sup></p>
      <p>The propolis extract used in this study was obtained from Lawang, East Java. It contained caffeic acid (2.56%), apigenin (1.05%), flavonoid (1.28%), saponin (0.82%), quercetin (1.03%), and terpenoid (1.15%) which account for its anti-microorganism, anti-tumor, anti-oxidant, immunomodulatory, and anti-inflammatory properties.‌<sup>[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>]</sup> Apigenin and quercetin constitute flavonoid derivatives. Each constituent element within the Lawang propolis extract possessed the ability to downregulate proinflammatory cytokines such as IL-1β, <abbrev xlink:title="interleukin-6" id="ABBRID0EZBAE">IL-6</abbrev>, and <abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0E4BAE">TNF-α</abbrev>, while also upregulating anti-inflammatory cytokines. Apigenin and caffeic acid also demonstrate the ability to inhibit osteoclastogenesis by deactivating nuclear factor kappa light chain enhancement.<sup>[<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]</sup></p>
      <p>The healing process is initiated by the hemostatic phase followed by the inflammation phase during which numerous proinflammatory cytokines are produced. This phase happens on the second and third days after extraction and is characterized by inflammatory cell migration. The residual cells and the product of the inflamed cell-induced apoptotic process will be phagocyted by macrophages. Proinflammatory cytokines such as IL-1β, <abbrev xlink:title="interleukin-6" id="ABBRID0ENCAE">IL-6</abbrev>, and <abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0ERCAE">TNF-α</abbrev> will be produced by macrophages and mast cells. Macrophages emerge in the late inflammation phase 48-72 hours after extraction and will be retracted to the wound area by chemoattractant agents such as cytokines.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup></p>
      <p>In osteoclastogenesis, proinflammatory cytokines execute important roles. For example, <abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0E4CAE">TNF-α</abbrev>, <abbrev xlink:title="interleukin-6" id="ABBRID0EBDAE">IL-6</abbrev>, and IL-1 can upregulate osteoclasts formation by upregulating the production of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFDAE">RANKL</abbrev> and M-CSF and increasing the responsivity of osteoclast precursors to <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJDAE">RANKL</abbrev>. <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ENDAE">RANKL</abbrev> plays the role of stimulating preosteoclast differentiation, the attachment of osteoclasts to bone tissue, and, subsequently, the activation and longevity of osteoclasts. The <abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0ERDAE">TNF-α</abbrev> that is released by activated macrophages can upregulate the production of proinflammatory cytokine and also <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EVDAE">RANKL</abbrev> by osteoblasts.<sup>[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B21">21</xref>]</sup></p>
      <p>In addition to <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFEAE">RANKL</abbrev>, osteoblasts regulate <abbrev xlink:title="osteoprotegerin" id="ABBRID0EJEAE">OPG</abbrev> expression. The analysis conducted in this study shows that <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ENEAE">RANKL</abbrev> expression had a significant negative correlation with <abbrev xlink:title="osteoprotegerin" id="ABBRID0EREAE">OPG</abbrev> expression in the third- and seventh-day observation groups. Negative correlation means that <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EVEAE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EZEAE">OPG</abbrev> have an inverse relation to each other. Similar to the results of other studies, this research found that when <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E4EAE">RANKL</abbrev> expression increases <abbrev xlink:title="osteoprotegerin" id="ABBRID0EBFAE">OPG</abbrev> expression will decrease relatively or, at least, <abbrev xlink:title="osteoprotegerin" id="ABBRID0EFFAE">OPG</abbrev> induction will be reduced, and vice versa. These processes can cause changes in the <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJFAE">RANKL</abbrev>/<abbrev xlink:title="osteoprotegerin" id="ABBRID0ENFAE">OPG</abbrev> ratio during osteoclastogenesis.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup></p>
      <p>Proinflammatory cytokines (<abbrev xlink:title="tumor necrosis factor-α" id="ABBRID0EZFAE">TNF-α</abbrev>, IL-1β, and <abbrev xlink:title="interleukin-6" id="ABBRID0E4FAE">IL-6</abbrev>) are ones that can induce osteoblasts to upregulate <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EBGAE">RANKL</abbrev> expression. If the expression of these cytokines is suppressed by the characteristics in propolis extract, <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFGAE">RANKL</abbrev> expression by osteoblast will decrease. Most of the factors that induce <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJGAE">RANKL</abbrev> expression by osteoblasts will also regulate <abbrev xlink:title="osteoprotegerin" id="ABBRID0ENGAE">OPG</abbrev>. The upregulation of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ERGAE">RANKL</abbrev> expression with the help of cytokines will also downregulate <abbrev xlink:title="osteoprotegerin" id="ABBRID0EVGAE">OPG</abbrev> expression.<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup> Therefore, the decreasing degree of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EAHAE">RANKL</abbrev> expression by osteoblasts in this study will also be followed by an increase in <abbrev xlink:title="osteoprotegerin" id="ABBRID0EEHAE">OPG</abbrev> expression.</p>
      <p>This study not only observed the mean number but, in addition, compared each group using the Tukey HSD test by means of which the significant differences in each group were located. <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EKHAE">RANKL</abbrev> expression on the third observation day showed that there were significant differences between the combination (propolis extract-<abbrev xlink:title="bovine bone graft" id="ABBRID0EOHAE">BBG</abbrev>) group and the other three groups. This indicated that <abbrev xlink:title="bovine bone graft" id="ABBRID0ESHAE">BBG</abbrev>, with its osteoconductive properties, and propolis extract, with its anti-inflammatory and antioxidant properties, worked together and decreased the number of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EWHAE">RANKL</abbrev> expression on the third observation day, which was the first peak of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E1HAE">RANKL</abbrev> expression.<sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup></p>
      <p>The <abbrev xlink:title="osteoprotegerin" id="ABBRID0EGIAE">OPG</abbrev> expression in the third day observation group showed significant differences between the control group and the <abbrev xlink:title="bovine bone graft" id="ABBRID0EKIAE">BBG</abbrev> group; the control group and the combination (propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0EOIAE">BBG</abbrev>) group. A nonsignificant difference was found between the combination (propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0ESIAE">BBG</abbrev>) group and the <abbrev xlink:title="bovine bone graft" id="ABBRID0EWIAE">BBG</abbrev> group; as well as the combination group and the propolis extract group. This might be because the peak <abbrev xlink:title="osteoprotegerin" id="ABBRID0E1IAE">OPG</abbrev> expression occurred on the first and seventh days after the bones had been injured. Therefore, the result for the third day observation group showed some insignificant differences.<sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup> The peaks of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EFJAE">RANKL</abbrev> expressions occurred on the third and fourteenth days, while those relating to <abbrev xlink:title="osteoprotegerin" id="ABBRID0EJJAE">OPG</abbrev> expressions manifested themselves on the first and seventh days after the wound had occurred. This study was conducted to observe <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ENJAE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0ERJAE">OPG</abbrev> expressions on the third and seventh days in order that they could be observed at their peak times.<sup>[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B23">23</xref>]</sup></p>
      <p><abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EBKAE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EFKAE">OPG</abbrev> expressions observed on the seventh day demonstrated the same results in terms of which groups had significant differences compared with other groups. The significant differences occurred between the control groups and the <abbrev xlink:title="bovine bone graft" id="ABBRID0EJKAE">BBG</abbrev> groups; the control groups and the combination groups; as well as the propolis extract groups and the combination groups. Apart from these groups, the results indicated no significant differences between the combination groups and the <abbrev xlink:title="bovine bone graft" id="ABBRID0ENKAE">BBG</abbrev> groups; the propolis extract groups and the control groups; or the propolis extract groups and the <abbrev xlink:title="bovine bone graft" id="ABBRID0ERKAE">BBG</abbrev> groups. There were no significant differences between the <abbrev xlink:title="bovine bone graft" id="ABBRID0EVKAE">BBG</abbrev> groups and the combination groups in terms of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EZKAE">RANKL</abbrev> expression on the seventh day, which may have been due to the fact that it was not supposed to be the peak of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0E4KAE">RANKL</abbrev> expression day. Moreover, the process may have happened earlier because the anti-inflammation effect of the propolis extract can accelerate the inflammation process. That is why the result was significant on the third observation day. <abbrev xlink:title="osteoprotegerin" id="ABBRID0EBLAE">OPG</abbrev> expression also demonstrated an insignificant difference on the seventh day possibly because it constitutes the second peak of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EFLAE">OPG</abbrev> production. Therefore, there is a possibility that the peak of <abbrev xlink:title="osteoprotegerin" id="ABBRID0EJLAE">OPG</abbrev> expression in this study happened on the first day with the result that it produced an insignificant result on the seventh day.<sup>[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]</sup></p>
      <p>In accordance with a number of earlier studies, the application of immunomodulatory and anti-inflammatory agents from the propolis extract in this study can decrease the magnitude and duration of inflammation. In cases of the overactivation of inflammatory cells, the healing process will be compromised. Proinflammatory cytokines released by macrophages can exacerbate the inflammatory reaction. Therefore, they need to be temporarily suppressed in order to promote more rapid healing.<sup>[<xref ref-type="bibr" rid="B24">24</xref>]</sup></p>
      <p>Certain results indicate that there are insignificant differences between the combination group and the <abbrev xlink:title="bovine bone graft" id="ABBRID0EBMAE">BBG</abbrev> group. However, the means may show a contrasting situation. For example, the means still indicate that <abbrev xlink:title="bovine bone graft" id="ABBRID0EFMAE">BBG</abbrev> groups have a lower level of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJMAE">RANKL</abbrev> expression and a higher degree of <abbrev xlink:title="osteoprotegerin" id="ABBRID0ENMAE">OPG</abbrev> expression when compared to the combination groups. Bone remodeling is a complex process influenced by various factors. Osteoclastogenesis, in which <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0ERMAE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EVMAE">OPG</abbrev> play important roles, is only one of the factors that influence it. For this reason, observation of other factors and markers is required in order to understand the entire bone remodeling process.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup></p>
      <p>The results of this study concur with those of the research conducted by Kresnoadi et al. in 2020 and Lunardhi et al. in 2019, which stated that the combination group (<abbrev xlink:title="bovine bone graft" id="ABBRID0EBNAE">BBG</abbrev> and propolis extract) show the highest mean number of osteoblasts and lowest mean number of osteoclasts on the third and seventh days. Kresnoadi et al. asserted that the combination of natural propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0EFNAE">BBG</abbrev> can increase HSP70 expression, osteocalcin, as well as the number of osteoblasts, while decreasing the number of osteoclasts.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup> The <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EQNAE">RANKL</abbrev> and <abbrev xlink:title="osteoprotegerin" id="ABBRID0EUNAE">OPG</abbrev> values obtained in this study parallel the number of osteoblasts and osteoclasts resulting from previous studies. The decreasing expression of <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EYNAE">RANKL</abbrev> and increasing expression of <abbrev xlink:title="osteoprotegerin" id="ABBRID0E3NAE">OPG</abbrev> after application of <abbrev xlink:title="bovine bone graft" id="ABBRID0EAOAE">BBG</abbrev>-propolis extract combination as a socket preservation material will help <abbrev xlink:title="osteoprotegerin" id="ABBRID0EEOAE">OPG</abbrev> bind to <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EIOAE">RANKL</abbrev> with the result that <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EMOAE">RANKL</abbrev> cannot bind to RANK. This will inhibit the initiation of osteoclast precursor differentiation.‌<sup>[<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]</sup> By impeding the process of osteoclastogenesis, it is anticipated that the healing process may occur more rapidly resulting in minimal bone resorption.</p>
    </sec>
    <sec sec-type="Conclusions" id="SECID0E2OAE">
      <title>Conclusions</title>
      <p>Based on the experiment conducted during this study, it can be concluded that the combination of propolis extract and <abbrev xlink:title="bovine bone graft" id="ABBRID0EBPAE">BBG</abbrev> effectively upregulates <abbrev xlink:title="osteoprotegerin" id="ABBRID0EFPAE">OPG</abbrev> expression and downregulates <abbrev xlink:title="receptor activator of nuclear κB ligand" id="ABBRID0EJPAE">RANKL</abbrev> expression in the preserved post-extraction-socket.</p>
    </sec>
    <sec sec-type="Funding" id="SECID0ENPAE">
      <title>Funding</title>
      <p>The authors have no funding to report.</p>
    </sec>
    <sec sec-type="Competing interests" id="SECID0ESPAE">
      <title>Competing interests</title>
      <p>The authors have declared that no competing interests exist.</p>
    </sec>
    <sec sec-type="Acknowledgements" id="SECID0EXPAE">
      <title>Acknowledgements</title>
      <p>The authors have no support to report.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple">1. Ministry of Health (MoH), Republic of Indonesia. National Institute of Health Research and Development. Basic Health Research 2018. doi: 1 December 2013</mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple">2. Hansson S, Halldin A. Alveolar ridge resorption after tooth extraction: A consequence of a fundamental principle of bone physiology. J Dent Biomech 2012; 3:1–8.</mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple">3. Abirami G, Samyukta. Residual ridge resorption in complete denture wearers. J Pharm Sci Res 2016; 8:565–69.</mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple">4. Araújo MG, Silva CO, Misawa M, et al. Alveolar socket healing: what can we learn? Periodontol 2000 2015; 68:122–34.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple">5. Mittal Y, Jindal G, Garg S. Bone manipulation procedures in dental implants. Indian J Dent 2016; 7:86–94.</mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple">6. Deshmukh J, Deshpande S, Khatri R, et al. Vertical and horizontal ridge augmentation in anterior maxilla using autograft, xenograft and titanium mesh with simultaneous placement of endosseous implants. J Indian Soc Periodontol 2014; 18:661.</mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple">7. Canullo L, Pellegrini G, Canciani E, et al. Alveolar socket preservation technique: Effect of biomaterial on bone regenerative pattern. Ann Anat 2016; 206:73–9.</mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple">8. Jamjoom A, Cohen R. Grafts for ridge preservation. J Funct Biomater 2015; 6:833–48.</mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple">9. Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab 2017; 14:209.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple">10. Oryan A, Alemzadeh E, Moshiri A. Potential role of propolis in wound healing: Biological properties and therapeutic activities. Biomed Pharmacother 2017; 98:469–83.</mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">11. Kresnoadi U, Rahayu RP. Combination of Aloe vera and xenograft induction on decreasing of NF-κB of tooth extraction socket preservation in Cavia cobaya. Dent J (Majalah Kedokt Gigi) 2016; 47:1–6.</mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple">12. Arnez MFM, Ribeiro LSN, Barretto GD, et al. RANK/RANKL/OPG expression in rapid maxillary expansion. Brazilian Dent J 2017; 28:296–300.</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple">13. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 2009; 37:1528–42.</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple">14. Nappe CE, Rezuc AB, Montecinos A, et al. Histological comparison of an allograft, a xenograft and alloplastic graft as bone substitute materials. J Osseointegration 2016; 8:20–6.</mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple">15. Anjum SI, Ullah A, Khan KA, et al. Composition and functional properties of propolis (bee glue): A review. Saudi J Biol Sci 2019; 26:1695–703.</mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple">16. Nagy V, Penninger JM. The RANKL-RANK Story. Gerontology 2015; 61:534–42.</mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple">17. Rolvien T, Barbeck M, Wenisch S, et al. Cellular mechanisms responsible for success and failure of bone substitute materials. Int J Mol Sci 2018; 19:1–16.</mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple">18. Khurshid Z, Naseem M, Zafar MS, et al. Propolis: A natural biomaterial for dental and oral health care. J Dent Res Dent Clin Dent Prospects 2017; 11(4):265–74.</mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple">19. Salehi B, Venditti A, Sharifi-Rad M, et al. The therapeutic potential of Apigenin. Int J Mol Sci 2019; 20. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3390/ijms20061305">10.3390/ijms20061305</ext-link>.</mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple">20. Di Gesso JL, Kerr JS, Zhang Q, et al. Flavonoid metabolites reduce tumor necrosis factor-α secretion to a greater extent than their precursor compounds in human THP-1 monocytes. Mol Nutr Food Res 2015; 59:1143–54.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple">21. Tobeiha M, Moghadasian MH, Amin N, et al. RANKL/RANK/OPG pathway: a mechanism involved in exercise-induced bone remodeling. Biomed Res Int 2020; 2020:1–11.</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple">22. Martin TJ, Sims NA. RANKL/OPG; Critical role in bone physiology. Rev Endocr Metab Disord 2015; 16:131–39.</mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple">23. Kon T, Cho TJ, Aizawa T, et al. Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 2001; 16:1004–14.</mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation xlink:type="simple">24. Nguyen VL, Truong CT, Nguyen BCQ, et al. Anti-inflammatory and wound healing activities of calophyllolide isolated from Calophyllum inophyllum Linn. PLoS One 2017; 12:1–16.</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation xlink:type="simple">25. Kresnoadi U, Rahayu RP, Ariani MD, et al. The potential of natural propolis extract combined with bovine bone graft in increasing heat shock protein 70 and osteocalcin on socket preservation. Eur J Dent 2020; 14:031–7.</mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation xlink:type="simple">26. Lunardhi LC, Kresnoadi U, Agustono B. The effect of a combination of propolis extract and bovine bone graft on the quantity of fibroblasts, osteoblasts and osteoclasts in tooth extraction sockets. Dent J (Majalah Kedokt Gigi) 2019; 52:126.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
